Adjuvant denosumab in early breast cancer: First results from the international …
Amgen, Inc. (NASDAQ: AMGN) announced that the FDA approved its Prolia – …
Rick Pendergraft: Now that we have entered earnings season, it is important to check the earnings calendar before you invest or make a trade. For instance, Amgen (NASDAQ:AMGN) appeared on my bullish scan yesterday, but I also …
May 17, 2018 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug ... integrity …
In DepthStreetInsider6d
Aimovig is priced at $6,900 a year, according to the company. Amgen stock (AMGN) rose $1.65, or about 1 percent, on Friday to close at $176.30 on the Nasdaq.
Amgen Inc. (NASDAQ: AMGN) is one the top blue-chip stocks in the biotech world ... Deutsche Bank has a $195 price objective for the stock. The Thomson/First Call consensus price target is $176.32. The stock closed Tuesday at $154.24.
May 21, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug ... integrity and availability of our systems and our data. Amgen's stock price may be volatile and may be affected by a number of …
In DepthIT Business Net2d
Within the health care space, Amgen (AMGN 176.30, +1.65) shares rallied 0.9% after the company ... Stocks Stumble As Yields Rise The stock market stumbled this week, giving back about a quarter of last week's advance, with the S&P …
Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted earnings of $1.23 non-GAAP EPS and $3.875 billion in revenues. First Call had estimates pegged at …
ASUS is one of Fortune magazine’s World’s Most Admired Companies, and is dedicated to creating products for today and tomorrow’s smart life. Our comprehensive portfolio includes Zenbo, ZenFone, ZenBook and a range of IT devices and …